ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1407
1,01%
Bitcoin
62.619,47
2,34%
Brent Oil
83,95
0,47%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Brooklyn ImmunoTherapeutics Inc (BTX)

  7. Brooklyn ImmunoTherapeutics Inc (BTX) Notícias

BTX

Brooklyn ImmunoTherapeut... (BTX)

Brooklyn ImmunoTherapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:BTX
DataHoraFonteTítuloCódigoCompanhia
11/05/202317:35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
10/05/202307:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202308:02Edgar (US Regulatory)Annual Report to Security Holders (ars)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202308:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202307:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
25/04/202310:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/04/202317:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202318:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202318:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/12/202218:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
16/12/202219:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/12/202218:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
06/12/202220:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
02/12/202219:01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
29/04/202217:35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
15/04/202218:10Edgar (US Regulatory)Annual Report (10-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
01/04/202207:31Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
29/11/202108:02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202119:12Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202119:00Edgar (US Regulatory)Withdrawal of Registration Statement (rw)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202118:52Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
09/11/202118:35GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial ResultsAMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202117:22Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202117:13Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202117:06Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/10/202117:15GlobeNewswire Inc.Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to NasdaqAMEX:BTXBrooklyn ImmunoTherapeutics Inc
12/10/202118:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
01/10/202117:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
23/09/202117:30GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Reports Inducement GrantsAMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/09/202111:07GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical OfficerAMEX:BTXBrooklyn ImmunoTherapeutics Inc
 Apresentando as notícias mais relevantes sobre:AMEX:BTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
PDTC3
Padtec ON
BOV
AZEV4
AZEVEDO PN
BOV
OIBR3
OI ON
BOV
VVEO3
CM Hospitalar ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
PRIO3
PETRORIO ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
ENJU3
Enjoei ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
ENAT3
ENAUTA ON
BOV
JHSF3
JHSF PART ON
BOV
SGPS3
SPRINGS ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados